This is a study of dulaglutide in Chinese participants. The purpose of the study is to
determine how the body processes dulaglutide and how dulaglutide affects the body. This study
has 2 parts: Part A - single dose of dulaglutide administered to healthy participants in 2 of
3 study periods. There is a minimum 28-day washout between periods. Part A will last
approximately 16 weeks. Part B - multiple doses of dulaglutide administered to participants
with Type 2 diabetes mellitus (T2DM). Part B will last approximately 15 weeks.
Doses of 0.5 milligrams (mg), 0.75 mg, and 1.5 mg of dulaglutide will be evaluated in this
study.